University of New Mexico at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

University of New Mexico takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on inflammation in the biomarker framework for dementia. Its work compares CSF, plasma and MRI markers of inflammation and tests a functional plasma tau assay in mouse models.

Organization	CTAD 2026 Attendance
University of New Mexico Albuquerque, New Mexico
	Poster Wed Nov 18 7:15am–5:30pm Use of the VeraBIND Tau Functional Plasma Assay to Detect Active Tau Pathology in Preclinical Mouse Models (P271) Blood and CSF biomarkers · Other mechanisms and targets Poster Wed Nov 18 7:15am–5:30pm Toward an inflammation axis for the ATN(V)I framework in dementia: CSF outperforms plasma and MRI biomarkers using the albumin index as a standard for inflammation (P273) Blood and CSF biomarkers · Other mechanisms and targets

Organization

CTAD 2026 Attendance

University of New Mexico

Albuquerque, New Mexico

Poster

Wed Nov 18
7:15am–5:30pm

Use of the VeraBIND Tau Functional Plasma Assay to Detect Active Tau Pathology in Preclinical Mouse Models (P271)

Blood and CSF biomarkers · Other mechanisms and targets

Poster

Wed Nov 18
7:15am–5:30pm

Toward an inflammation axis for the ATN(V)I framework in dementia: CSF outperforms plasma and MRI biomarkers using the albumin index as a standard for inflammation (P273)

Blood and CSF biomarkers · Other mechanisms and targets

Instantly find 20 buyers from University of New Mexico

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction